The effects of alpha-2 agonist, medetomidine and its antagonist, atipamezole on reaction and movement times in a visual choice reaction time task in monkeys

Brain Research Bulletin

Volumn 44, Issue 2, 1997, Pages 171-175

  Rämä, Pia ^a   Linnankoski, Ilkka ^a   Carlson, Synnöve ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Alpha 2 adrenoceptor drugs; Monkeys; Movement time; Reaction time; Visual choice reaction time task

Indexed keywords

ATIPAMEZOLE; MEDETOMIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DIODE; MENTAL PERFORMANCE; MONKEY; MOTOR DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; REACTION TIME; RECEPTOR AFFINITY; RECEPTOR BINDING; SHORT TERM MEMORY; TASK PERFORMANCE;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BEHAVIOR, ANIMAL; CHOICE BEHAVIOR; CUES; IMIDAZOLES; MACACA; MEDETOMIDINE; MOVEMENT; PHOTIC STIMULATION; REACTION TIME; TIME FACTORS;

EID: 0030819615     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(97)00108-1     Document Type: Article

References (28)

1. Arnsten A. F. T., Goldman-Rakic P. S. Alpha2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science. 230:1985;1273-1276.
2. Arnsten A. F. T., Cai J. X., Goldman-Rakic P. S. The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: Evidence for alpha-2 receptor subtypes. J. Neurosci. 8:1988;4287-4298.
3. Arnsten A. F. T., Goldman-Rakic P. S. Analysis of alpha-2 adrenergic agonist effects on the delayed nonmatch-to-sample performance of aged rhesus monkeys. Neurobiol. Aging. 11:1990;583-590.
4. Arnsten A. F. T., Leslie F. M. Behavioral and receptor binding analysis of the alpha2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-YL amino] quinoxaline (UK-14304): Evidence for cognitive enhancement at an alpha2-adrenoceptor subtype. Neuropharmacology. 30:1991;1279-1289.
5. Arnsten A. F. T., Contant T. A. Alpha-2 adrenergic agonists decrease distractibility in aged monkeys performing the delayed response task. Psychopharmacology (Berlin). 108:1992;159-169.
6. Arnsten A. F. T., Steere J. C., Hunt R. D. The contribution of alpha2-noradrenergic mechanisms to prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch. Gen. Psychiatry. 53:1996;448-455.
7. Bartus R. T., Dean R. L. Lack of efficacy of clonidine on memory in aged Cebus monkeys. Neurobiol. Aging. 9:1988;409-411.
8. Carlson S., Tanila H., Rämä P., Mecke E., Pertovaara A. Effects of medetomidine, an alpha-2 adrenoceptor agonist, and atipamezole, an alpha-2 antagonist, on spatial memory performance in adult and aged rats. Behav. Neural Biol. 58:1992;113-119.
9. Davis R. E., Callahan M. J., Downs D. A. Clonidine disrupts aged-monkey delayed response performance. Drug Dev. Res. 12:1988;279-286.
10. Fuster J. M. Unit activity in prefrontal cortex during delayed-response performance: Neuronal correlates of transient memory. J. Neurophysiol. 36:1973;61-78.
11. Goldman P. S., Rosvold H. E. Localization of function within the dorsolateral prefrontal cortex of the rhesus monkey. Exp. Neurol. 27:1970;291-304.
12. Goldman-Rakic P. S. Circuitry of primate prefrontal cortex and regulation of behavior by representational memory. Handbook of physiology. The nervous system. Higher functions of the brain. 5:1987;373-417 Am. Physiol. Soc, Bethesda, MD.
13. Jackson W. J., Buccafusco J. J. Clonidine enhances delayed matching-to-sample performance by young and aged monkeys. Pharmacol. Biochem. Behav. 39:1991;79-84.
14. Jäkälä P., Sirviö J., Riekkinen P. Jr., Haapalinna A., Riekkinen P. Effects of atipamezole, an alpha2-adrenoceptor antagonist, on the performance of rats in a five-choice serial reaction time task. Pharmacol. Biochem. Behav. 42:1992;903-907.
15. Kauppila T., Tanila H., Carlson S., Taira T. Effects of atipamezole, a novel alpha2-adrenoceptor antagonist, in open-field, plus-maze, two compartment exploratory, and forced swimming tests in the rat. Eur. J. Pharmacol. 205:1991;177-182.
16. Keele S. W. Motor control. Boff K. R., Kaufman L., Thomas J. P. Handbook of perception and human performance. Cognitive processes and performance. II:1986;Wiley & Sons, Inc, New York.
17. MacDonald E., Haapalinna A., Virtanen R., Lammintausta R. Effects of acute administration of medetomidine on the behaviour, temperature and turnover rates of brain biogenic amines in rodents and reversal of these effects by atipamezole. Acta Vet. Scand. 85:1989;77-81.
18. Riekkinen P. Jr., Sirviö J., Riekkinen M., Lammintausta R., Riekkinen P. Atipamezole, an alpha-2 antagonist, stabilizes age-related high-voltage spindle and passive avoidance defects. Pharmacol. Biochem. Behav. 41:1992;611-614.
19. Ruotsalainen S., Haapalinna A., Riekkinen P. J. Sr., Sirviö J. Dexmedetomidine reduces response tendency, but not accuracy of rats in attention and short-term memory tasks. Pharmacol. Biochem. Behav. 56:1997;31-40.
20. Rämä P., Linnankoski I., Tanila H., Pertovaara A., Carlson S. Medetomidine, atipamezole, and guanfacine in delayed response performance of aged monkeys. Pharmacol. Biochem. Behav. 55:1996;415-422.
21. Scheinin H., Virtanen R., MacDonald E., Lammintausta R., Scheinin M. Medetomidine - A novel alpha2-adrenoceptor agonist: A review of its pharmacodynamic effects. Prog. Neuropsychopharmacol. Biol. Psychiatry. 13:1989;635-651.
22. Sirviö J., Lukkarinen K., Riekkinen P. Jr., Koivisto E., Virtanen R., Pennanen A., Valjakka A., Riekkinen P. J. The effects of atipamezole, an alpha-2 antagonist, on the performance of young and aged rats in the delayed nonmatching to position task. Pharmacol. Biochem. Behav. 39:1991;1015-1019.
23. Sirviö J., Riekkinen P. Jr., MacDonald E., Airaksinen M., Lammintausta R., Riekkinen P. J. The effects of alpha-2 adrenoceptor antagonist, atipamezole, on spatial learning in scopolamine-treated and aged rats. J. Neural Transm. [Parkinsons Disease Dementia Sect.]. 4:1992;99-106.
24. Sirviö J., Mazurkiewicz M., Haapalinna A., Riekkinen P. Jr., Lahtinen H., Riekkinen P. J. Sr. The effects of selective alpha-2 adrenergic agents on the performance of rats in a 5-choice serial reaction time task. Brain Res. Bull. 35:1994;451-455.
25. Tanila H., Rämä P., Carlson S. The effects of prefrontal intracortical microinjections of an alpha-2 agonist, alpha-2 antagonist and lidocaine on the delayed alternation performance of aged rats. Brain Res. Bull. 40:1996;117-119.
26. 2A-selective compound. Eur. J. Pharmacol. 202:1991;235-243.
27. 3H]-MK 912 binding delineates two alpha2-adrenoceptor subtypes in rat CNS one of which is identical with the cloned pA2d alpha2-adrenoceptor. Br. J. Pharmacol. 106:1992;986-995.
28. Virtanen R., Savola J.-M., Saano V., Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an alpha2-adrenoceptor agonist. Eur. J. Pharmacol. 150:1988;9-14.